Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.

I call it my AI Retirement Playbook. I recommend you check it out now.

Antal Desai Biography and Net Worth

Director of PROCEPT BioRobotics

Mr. Desai has served as a member of our board of directors since June 2015. Mr. Desai joined Cardinal Investment Company, Inc. in September 2004, the predecessor firm to CPMG, Inc., an investment firm that invests in publicly-traded and private companies globally, were he currently serves as a Partner. Mr. Desai is a member of the board of directors of several private companies. Mr. Desai received both a B.S. in Economics and an M.B.A. from the Wharton School at the University of Pennsylvania.

What is Antal Rohit Desai's net worth?: The estimated net worth of Antal Rohit Desai is at least $13.34 million as of November 7th, 2024. Mr. Desai owns 164,363 shares of PROCEPT BioRobotics stock worth more than $13,341,345 as of December 21st. This net worth approximation does not reflect any other investments that Mr. Desai may own. Learn More about Antal Rohit Desai's net worth.
How do I contact Antal Rohit Desai?: The corporate mailing address for Mr. Desai and other PROCEPT BioRobotics executives is 900 ISLAND DRIVE, REDWOOD CITY CA, 94065. PROCEPT BioRobotics can also be reached via phone at 650-232-7200 and via email at [email protected]. Learn More on Antal Rohit Desai's contact information.
Has Antal Rohit Desai been buying or selling shares of PROCEPT BioRobotics?: Within the last three months, Antal Rohit Desai has sold $6,431,060.00 in shares of PROCEPT BioRobotics stock. Most recently, Antal Rohit Desai sold 34,000 shares of the business's stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $95.39, for a transaction totalling $3,243,260.00. Following the completion of the sale, the director now directly owns 164,363 shares of the company's stock, valued at $15,678,586.57. Learn More on Antal Rohit Desai's trading history.
Who are PROCEPT BioRobotics' active insiders?: PROCEPT BioRobotics' insider roster includes Antal Desai (Director), Frederic Moll (Director), Alaleh Nouri (EVP), Hisham Shiblaq (EVP, Chief Commercial Officer), Kevin Waters (EVP, CFO), and Reza Zadno (CEO). Learn More on PROCEPT BioRobotics' active insiders.
Are insiders buying or selling shares of PROCEPT BioRobotics?: In the last twelve months, insiders at the sold shares 30 times. They sold a total of 856,645 shares worth more than $68,624,097.76. The most recent insider tranaction occured on December, 4th when CEO Reza Zadno sold 26,423 shares worth more than $2,568,844.06. Insiders at PROCEPT BioRobotics own 17.4% of the company. Learn More about insider trades at PROCEPT BioRobotics.
Information on this page was last updated on 12/4/2024.

Antal Rohit Desai Insider Trading History at PROCEPT BioRobotics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/7/2024	Sell	34,000	$95.39	$3,243,260.00	164,363
11/5/2024	Sell	33,000	$96.60	$3,187,800.00	231,363
9/12/2024	Sell	44,867	$80.11	$3,594,295.37	197,453
9/10/2024	Sell	36,500	$76.18	$2,780,570.00	281,018
9/5/2024	Sell	13,305	$76.37	$1,016,102.85	317,518
9/3/2024	Sell	35,220	$76.12	$2,680,946.40	23,963

Antal Rohit Desai Buying and Selling Activity at PROCEPT BioRobotics

PROCEPT BioRobotics Company Overview

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Today's Range

Now: $81.17

$79.41

$82.28

50 Day Range

MA: $88.25

$66.83

$99.45

2 Week Range

Now: $81.17

$39.48

$103.81

Volume

1,287,977 shs

Average Volume

653,331 shs

Market Capitalization

$4.24 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99

First JFK… next Elon?

From Porter & Company | Ad

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.